Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron

Manuela Di Fusco, Xiaowu Sun, Mary M. Moran, Henriette Coetzer, Joann M. Zamparo, Mary B. Alvarez, Laura Puzniak, Ying P. Tabak, Joseph C. Cappelleri
doi: https://doi.org/10.1101/2023.03.15.23286981

Article Information

doi 
https://doi.org/10.1101/2023.03.15.23286981
History 
  • March 17, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Manuela Di Fusco1,*,
  2. Xiaowu Sun2,
  3. Mary M. Moran3,
  4. Henriette Coetzer2,
  5. Joann M. Zamparo4,
  6. Mary B. Alvarez5,
  7. Laura Puzniak3,
  8. Ying P. Tabak2 and
  9. Joseph C. Cappelleri6
  1. 1Pfizer Inc, Health Economics and Outcomes Research, New York, NY, USA
  2. 2CVS Health, Woonsocket, RI, USA
  3. 3Pfizer Inc, MDSCA Vaccines, Collegeville, PA, USA
  4. 4Pfizer Inc, Groton, CT, USA
  5. 5Pfizer Inc, Field Medical Outcomes and Analytics, New York, NY, USA
  6. 6Pfizer Inc, Statistical Research and Data Science Center, Groton, CT, USA
  1. ↵*Corresponding author:
    Manuela Di Fusco, Health Economics and Outcomes Research, Pfizer, Inc., New York, NY, USA, Manuela.difusco{at}pfizer.com
Back to top
Posted March 17, 2023.
Download PDF
Data/Code
Email
Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron
Manuela Di Fusco, Xiaowu Sun, Mary M. Moran, Henriette Coetzer, Joann M. Zamparo, Mary B. Alvarez, Laura Puzniak, Ying P. Tabak, Joseph C. Cappelleri
medRxiv 2023.03.15.23286981; doi: https://doi.org/10.1101/2023.03.15.23286981
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area